We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Modine Manufacturing
MOD
$9.46B
| $339K | 0.01% |
3,437
-13,397
| -80% | -$1.2M |
|
|
VSXY
1327
Victoria's Secret
VSXY
$7.09B
| $338K | 0.01% |
18,266
+2,133
| +13% | +$41.7K |
|
1328
NETSCOUT
NTCT
$2.83B
| $337K | 0.01% |
13,603
-7,521
| -36% | -$167K |
|
1329
Avnet
AVT
$6.86B
| $337K | 0.01% |
+6,356
| New | +$316K |
|
1330
Gorman-Rupp
GRC
$2.07B
| $335K | 0.01% |
9,123
+2,553
| +39% | +$91.8K |
|
1331
Wabtec
WAB
$49.3B
| $334K | 0.01% |
+1,594
| New | +$307K |
|
1332
Ocugen
OCGN
$403M
| $333K | 0.01% |
+343,557
| New | +$285K |
|
1333
Haleon
HLN
$45.3B
| $332K | 0.01% |
32,022
-40,352
| -56% | -$426K |
|
1334
National Vision
EYE
$1.76B
| $329K | 0.01% |
+14,307
| New | +$244K |
|
1335
Bumble
BMBL
$387M
| $327K | 0.01% |
49,587
+32,575
| +191% | +$164K |
|
1336
State Street SPDR S&P Insurance ETF
KIE
$664M
| $326K | 0.01% |
5,456
-1,770
| -24% | -$103K |
|
1337
Oxford Industries
OXM
$581M
| $325K | 0.01% |
+8,081
| New | +$406K |
|
1338
F5
FFIV
$22B
| $325K | 0.01% |
1,104
-4,913
| -82% | -$1.36M |
|
1339
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
| $325K | 0.01% |
3,296
-3,607
| -52% | -$343K |
|
1340
SEI Investments
SEIC
$12.3B
| $322K | 0.01% |
+3,585
| New | +$289K |
|
1341
Atossa Therapeutics
ATOS
$23M
| $321K | 0.01% |
+25,756
| New | +$308K |
|
|
BBT
1342
Beacon Financial Corp
BBT
$2.5B
| $318K | 0.01% |
+12,703
| New | +$316K |
|
1343
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.69B
| $317K | 0.01% |
+5,487
| New | +$299K |
|
1344
Stoneridge
SRI
$200M
| $315K | 0.01% |
+44,750
| New | +$219K |
|
1345
Vermilion Energy
VET
$1.66B
| $315K | 0.01% |
43,243
+22,236
| +106% | +$152K |
|
1346
Donegal Group Class A
DGICA
$715M
| $313K | 0.01% |
+15,635
| New | +$303K |
|
|
ARI
1347
Apollo Commercial Real Estate
ARI
$864M
| $312K | 0.01% |
32,207
-61,005
| -65% | -$575K |
|
1348
Compass
COMP
$8.67B
| $312K | 0.01% |
49,628
-16,171
| -25% | -$111K |
|
1349
iShares MSCI India ETF
INDA
$6.81B
| $311K | 0.01% |
+5,594
| New | +$299K |
|
1350
Hubbell
HUBB
$24.4B
| $311K | 0.01% |
762
-12,126
| -94% | -$4.5M |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.